Table I.
5-AC | Cytarabine | |
---|---|---|
Group 1 | 37.5 mg/m2/day IV over 20–30 min daily ×7 | 100 mg/m2/day continuous intravenous infusion (CIV) ×7 days |
Group 2 | 75 mg/m2/day IV over 20–30 min daily ×7 | 100 mg/m2/day continuous intravenous infusion (CIV) ×7 days |
Group 3 | 37.5 mg/m2/day IV over 20–30 min daily ×7 | 1g/m2/day CIV days 1–4 (age <65 years) or days 1–3 (age ≥65 years) |
Group 4 | 75 mg/m2/day IV over 20–30 min daily ×7 | 1g/m2/day CIV days 1–4 (age <65 years) or days 1–3 (age ≥65 years) |